NovaBridge Biosciences Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

166.30M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	632.00K	2.18M	-
Dec 31, 2022	-1.55M	-15.40M	-
Dec 31, 2021	13.85M	-222.30M	-94.14%
Dec 31, 2020	236.15M	231.84M	5,381.19%
Dec 31, 2019	4.31M	2.53M	142.56%
Dec 31, 2017	1.78M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Biotest GmbH & Co. KGaA	648.90M
Darwin AG	54.30M
Paion AG	14.81M
2invest AG	8.89M
MagForce AG	1.08M
Biomark Diagnostics	57.01K
co.don AG	22.00K
bioXXmed AG	20.49K

Revenue Rankings

NovaBridge Biosciences News

11 days ago - NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer - GlobeNewsWire
23 days ago - NovaBridge Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
4 weeks ago - NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
5 weeks ago - NovaBridge Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
6 weeks ago - NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
2 months ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire
2 months ago - NovaBridge Biosciences Slides: Company presentation - Filings
2 months ago - NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire

More News